|
ID2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.013640E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.801800E-02 |
| Normal-vs-Stage2 |
2.042200E-01 |
| Normal-vs-Stage3 |
2.787800E-01 |
| Normal-vs-Stage4 |
6.374000E-01 |
| Stage1-vs-Stage2 |
8.260000E-01 |
| Stage1-vs-Stage3 |
2.641800E-01 |
| Stage1-vs-Stage4 |
1.342060E-03 |
| Stage2-vs-Stage3 |
5.952000E-01 |
| Stage2-vs-Stage4 |
8.316000E-02 |
| Stage3-vs-Stage4 |
6.907900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.507600E-02 |
| Normal-vs-AfricanAmerican |
1.527830E-01 |
| Normal-vs-Asian |
5.056600E-01 |
| Caucasian-vs-AfricanAmerican |
7.137200E-01 |
| Caucasian-vs-Asian |
3.229600E-01 |
| AfricanAmerican-vs-Asian |
3.420800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.802400E-01 |
| Normal-vs-Female |
6.156300E-02 |
| Male-vs-Female |
4.549800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.892040E-02 |
| Normal-vs-Age(41-60Yrs) |
2.695800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.107200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.312600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.792100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.175500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.625170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.973400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.142200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.110600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.991900E-02 |
| Classical-VS-Follicular |
9.801800E-01 |
| Classical-VS-Other |
1.278820E-01 |
| Classical-VS-Normal |
4.242100E-02 |
| Tall-VS-Follicular |
1.040960E-01 |
| Tall-VS-Other |
4.144400E-01 |
| Tall-VS-Normal |
9.800800E-01 |
| Follicular-VS-Other |
2.480600E-01 |
| Follicular-VS-Normal |
1.132610E-01 |
| Other-VS-Normal |
4.855200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.258800E-01 |
| Normal-vs-N1 |
5.232000E-01 |
| N0-vs-N1 |
2.836600E-01 |
|
|
